Sleep Disorders

>

Latest News

SURMOUNT-OSA: Tirzepatide Improves Sleep Apnea Symptoms, CV Outcomes in Adults with OSA and Obesity / Image credit: ©motortion/AdobeStock
SURMOUNT-OSA: Tirzepatide Improves Sleep Apnea Symptoms, CV Outcomes in Adults with OSA and Obesity

June 24th 2024

ADA 2024. Adults with OSA and obesity receiving tirzepatide had improvements in sleep apnea severity and systolic blood pressure compared to placebo.

ADA 84th Scientific Sessions: 3 Studies Primary Care Clinicians Should Put on Their Radar / Image credit: ©lyrna/AdobeStock
ADA 84th Scientific Sessions: 3 Studies Primary Care Clinicians Should Put on Their Radar

June 20th 2024

ADA 84th Scientific Sessions Preview: STEP-HFp-EF Trial Data, Tirzepatide for Obesity-Related OSA, Optimizing Diabetes Care in Primary Care / Image credit: ©Minerva Studio/Shutterstock.com
ADA 84th Scientific Sessions Preview: STEP-HFp-EF Trial Data, Tirzepatide for Obesity-Related OSA, Optimizing Diabetes Care in Primary Care

June 17th 2024

Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Regulatory Submission  / image credit obese man asleep / ©motortion/stock.adobe.com
Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Mid-2024 Regulatory Submission

April 17th 2024

Women with Poor Sleep During Midlife at Significantly Elevated Risk for Future CVD / image credit woman with insomnia ©motortion/stock.adobe.com
Women with Poor Sleep During Midlife at Significantly Elevated Risk for Future CVD

February 13th 2024

Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.